Are you struggling with writing your Lupus research paper?

We understand the challenges and

complexities that come with such an endeavor. Crafting a thesis on Lupus requires not only extensive
research but also a deep understanding of the subject matter. From navigating through vast amounts
of literature to formulating a coherent argument, the process can be daunting.

Lupus is a complex autoimmune disease that presents unique challenges for researchers and scholars.
From understanding its etiology to exploring treatment options, there are numerous facets to consider
when delving into this topic. Additionally, the ever-evolving nature of medical research means that
staying up-to-date with the latest findings is essential for producing a comprehensive and relevant
thesis.

If you're feeling overwhelmed or unsure where to begin, consider seeking assistance from
professionals who specialize in academic writing. ⇒ BuyPapers.club ⇔ offers expert guidance and
support to students tackling complex topics like Lupus. Our team of experienced writers can help
you craft a well-researched and meticulously written thesis that meets the highest academic
standards.

By outsourcing your Lupus research paper to ⇒ BuyPapers.club ⇔, you can alleviate the stress
and pressure associated with the writing process. Our writers will work closely with you to
understand your unique requirements and ensure that your thesis effectively communicates your
ideas and insights. With our assistance, you can confidently submit a high-quality paper that
showcases your expertise and dedication to the field of Lupus research.

Don't let the challenges of writing a thesis on Lupus hold you back. Trust ⇒ BuyPapers.club ⇔ to
provide the support and guidance you need to succeed. Order now and take the first step towards
academic excellence.
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence
to date. This disease has inflammatory of small and medium sized arteries and arterioles. The phase II
clinical trial of 112 patients showed that the KLH IgG reaction decreased significantly, but the KLH
IgM reaction or IgG level had no obvious change. It was long ago observed that Systemic Lupus was
far more common in females than males, approximately with a ratio of 9:1 Rider et al, 1998. The
most common side effects are stomach upset, abdominal pain, ulcers, and even ulcer bleeding. All
these 50 patients were taken from the Northwestern Memorial Hospital at Chicago, Illinois, and they
were considered qualified for the experimental study mainly because of their medication history. For
these patients, whose SLE is treatment-refractory, what was recommended was “nonmyeloablative
hematopoietic stem cell transplantation, or HSCT, regimen” (Burt et al., 2006). Based on previous
studies and research and on what was previously known through theory, HSCT is a 2-step medical
procedure. Seizures may ensue from intellectual vasculitis, cardiac intercalation, timeserving
infection, drug poisoning, or associated metabolic mental unsoundnesss. This condition is closely
related to lupus as it ensures that transplantations can be done and thus correcting the lupus diseases.
Another diagnostic tool that is used, that of the study of the serum creatinine levels, can not only
diagnose chronic renal failure, but also help to distinguish it from acute renal failure, as the acute
version would see a rapid and sudden spike in the serum creatinine levels over several days or several
weeks, as opposed to a gradual rise that is seen over months or even over years ogers, 2004. The
biochemical hallmark of apoptotic cell death is the degradation of DNA into oligosome-sized
fragments by specific endonucleases and the formation of small vesicles from the cell surface, also
known as apoptotic bodies. Therefore, what is important is to find out if certain specific methods
work best with patients who are severely suffering from the disease or those who do not respond to
current strategies and medication. Systemic Lupus Erythematosus while being a visual disease it also
has some internal problems. First published in German in 1929, Civilization and its Discontents
delves deeply into Freud's theories of aggression, the death drive, and its adversary, Eros. There is a
peak age of onset in young women between their late teens and early 40s and women to men ratio
of 9:1. SLE has abnormalities in apoptosis (a programmed cell death).SLE is”the great imitator” it
oftenmimics or is mistaken for other illnesses. In a case report, a woman with psoriasis vulgaris that
was complicated with refractory lupus nephritis was treated with secukinumab for elevated Th17
cells in her peripheral blood and substantial IL-17 infiltration in her renal interstitium, despite
resistance to conventional treatment ( 75 ). Cytokine profiling in active and quiescent SLE reveals
distinct patient subpopulations. Furthermore, most of the studies focus on SLE and a systematic
epidemiological analysis of the various subtypes of CLE has not been conducted. The incidence of
adverse events was higher in the ustekinumab group (78%) than in the placebo group (67%), with
infection being the most common event. The FDA has approved tocilizumab for the treatment of
RA, but its use in SLE has not been well developed, given that it inhibits inflammatory responses
and increases the risk of infection at the same time. He looks forward a long way, believing that the
next quarter of a century will bring about great advances in both understanding and the management
of the condition. These include a broad assortment of neurological and psychiatric characteristics that
account for considerable morbidity and mortality in these patients. SLE has a gender-based and
ethnicity- based prevalence, with more cases observed in females than males and African population
than Caucasians. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis:
the Lupus Nephritis assessment with rituximab study. The number of white blood cells, platelets and
red blood cells are counted and their ratio known. Brief report: a randomized, double-blind, parallel-
group, placebo-controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus
erythematosus and active lupus arthritis. Antigenic liposomes displaying CD22 ligands induce
antigen-specific B cell apoptosis. Bispecific antibodies: a mechanistic review of the pipeline. The
stem cell technology will also come as a relief to nurses since they would not have to spend lots of
time taking care of the patients. It talks about perplexing statistics sing these two issues.
Original Article Lupus (1) For Later 0 ratings 0% found this document useful (0 votes) 40 views 6
pages Original Article Lupus Uploaded by Azhari Ahsan AI-enhanced title lupus Full description
Save Save 4. It was late, but I always enjoyed driving late at night when the roads are almost empty.
Another study showed that key secondary endpoints were not met and that side effects were
depression and suicidality ( 19 ). The main goal when it comes to the treatment is to prevent our
immune system from attacking itself. In this test, blood sample is taken and kept in a test tube from
where the rate at which the red blood cells settle at the bottom of the test tube is measured. In the
case of lupus the results of this attack are widespread and involve such things as joint damage,
inflammation of tendons and the whole connective tissue system as well as organs. Both molecules
play an important role in the maturation and migration of B cells. Despite the fact that physicians and
researchers seem to know a great deal about the onset and progression of the disease, the ontogenesis
of lupus is still unknown. In systemic lupus erythematosus, the damage which occurs on the tissues is
caused by immune complexes and antibodies. As a result of this, the immune system directs
antibodies to normal tissues thinking that they are foreign materials. Our understanding of the use of
combinations of antimalarial agents and proper dosing according to the ideal body weight limits
problems with toxicity. It is composed of the Fc of epratuzumab and four Fabs of veltuzumab, and a
CD20-targeting immunocytokine, using the Dock-and-Lock (DNL) method ( Figure 2L ). It has
been demonstrated that broadband sunscreens can suppress the induction of skin lesions by UV
irradiation in patients with CLE. BAFF is not only involved in the activation of B cells but also
promotes the proliferation of Th17 cells, thereby mediating the downstream immune response.
Historically, the disease was first recognized and evaluated by its visible cutaneous symptoms before
the analysis and study of its systemic organ manifestations established the complex nature of LE.
Despite this, the association between active EBV infection and the precipitation of SLE remains ill-
defined. The patient’s pretransplantation medical history served as the only secondary data used in
the study. First, the researchers have concluded that HSCT was effective in the treatment of SLE and
in the alleviation of its symptoms, with its probability of disease-free survival rate at 55% for five
years based on a European analysis and 50% based on this actual study. SAP is a member of a
family of proteins termed pentraxins that bind to apoptotic cells and then interact directly with
phagocyte receptors or with C1q. Conventional treatments, mainly including glucocorticoids and
immunosuppressants, have poor specificity and are prone to tolerance. In 1977, Gilliam developed a
classification system that divided the cutaneous lesions into LE-specific and LE-nonspecific
manifestations by histological analysis of skin biopsy specimens. Therefore, consequent protection
against UV light as well as other physical and mechanical injuries may be of significant value for the
course and prognosis of both CLE and SLE (Table 2). However, the clearance of UV-induced
apoptotic keratinocytes was not observed to be altered in C1qdeficient mice. Generation and
characterization of LymphoStat-B,a human monoclonal antibody that antagonizes the bioactivities of
B lymphocyte stimulator. If these aforementioned levels have improved or normalized after the
patient has undergone HSCT. Treatment Just like the difference in symptoms, the treatment of lupus
is also different. Since the initial formulation of the Gilliam nomenclature and classification system
more than two decades ago, several attempts have been made to improve on this system and to
provide new approaches to the problem of classification of the cutaneous manifestations of LE.
Upload Read for free FAQ and support Language (EN) Sign in Skip carousel Carousel Previous
Carousel Next What is Scribd. Immune abnormalities are mainly the loss of tolerance and sustained
autoantibody production ( 1 ). Type I interferon inhibitor anifrolumab in active systemic lupus
erythematosus (TULIP-1): a randomised, controlled, phase 3 trial.
Kimberly, 2001, Journal of American Medicine, February 2001,Volume 285,, number 5, 650 and 651
pages This is a relatively short article, only a page and a half, but covers many aspects of the
treatment, and possible future treatments of systemic lupus erythematosus. Interest in individual
performers, in the era of iTunes, was being relegated to the sidelines as teens assembled their own
'mixes' rather than sought to embrace the output of an individual artist. One in every five. 3. Swelling
and pain of the join. CD20 exists in the late pre-B cells and goes through the maturation stage of B
cells ( 31 ). Symptoms It is important to note that lupus is very variable. Journal of the American
Medical Association, 295(5), 527-535. The patient’s pretransplantation medical history served as the
only secondary data used in the study. In cynomolgus monkeys, B cells were reduced significantly
after treatment with AMG570. A phase III, randomized, placebo-controlled study of belimumab, a
monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus
erythematosus. According to Burt et al. (2006), a European analysis made up of data from 53
patients in 23 centers reported that patients with SLE undergoing autologous HSCT as well as
condition regimens increased their disease-free survival rate to 55%. In the case that
immunosuppressive agents and hormone therapy are ineffective, biological agents are used to control
the disease ( 116 ). However, most of the biological agents are still in the phase II and III clinical
stages or even in the preclinical stage, and have poor efficacy, side effects and other issues. The per
centum of patients with SLE enduring from cognitive upset varies among surveies. The damage is
due to the inflammation that is caused by direct antibody reaction to the body tissues as well the
deposition of immune complexes. Because of random assembly of the different chains, the design of
IgG-like BsAbs mainly focuses on how to solve the mismatch between two different heavy chains
and the mismatch between heavy chains and light chains. Therefore, the use of therapeutic
antibodies for in vitro immunosorbent therapy is also a promising application. MZ did the editing.
HW and QL revised the manuscript. The consequences are instead conflicting, nevertheless, and do
non let for a unequivocal decision. Blocking this pathway indirectly inhibits the proliferation and
activation of B cells and down-regulates autoantibody production, thus achieving a therapeutic
effect ( 48, 49 ). Flannery O'Connor is considered to be one of the greatest short story writers of the
twentieth century. Patients diagnosed with lupus undergo a lot of suffering, but it is possible to help
them by dealing with the symptoms and teaching them to go on with their lives. The level of TNF
reflects the disease activity (DA) level of SLE and is positively correlated with the activity of lupus
nephritis ( 86 ). Prospective observational single-centre cohort study to evaluate the effectiveness of
treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Currently in
preclinical studies, MT-6194 inhibits inflammation better than each cytokine alone in a mouse model
of delayed hypersensitivity inflammation ( 111 ). The first is the increase in the number of
mechanisms of action ( 115 ), which can simultaneously target multiple activation pathways and more
robustly inhibit immune responses. CXCL13 antibody for the treatment of autoimmune disorders.
Chemotherapy alone would never work and neither would autologous HSCT alone. The anti-CD80
primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed
Hodgkin lymphoma: cancer and leukemia group B 50602 (Alliance). Keep on browsing if you are
OK with that, or find out how to manage cookies. It is characterized by an autoantibody response to
nuclear and cytoplasmic antigens.
CXCL13 promotes proliferation of mesangial cells by combination with CXCR5 in SLE. However,
they have some side effects such as kidney bleeding and stomach bleeding. 2. Another treatment
method is the use of malaria drugs. In this review, we will summarize the existing biological agents,
expound on their effects at different sites ( Figure 1 ), and hope to shed light on future research to
develop more targeted therapy. Anti-malarial drugs are generally regarded as suitable in the earlier
stage. Another study showed that key secondary endpoints were not met and that side effects were
depression and suicidality ( 19 ). These include a broad assortment of neurological and psychiatric
characteristics that account for considerable morbidity and mortality in these patients. Nevertheless,
studies on CLE did not encompass a general T reg defect as supported by a normal frequency of
circulating T reg subpopulation and by a normal capacity to suppress T con proliferation. This figure
shows the sites of action of some therapeutic antibodies with a focus on B cells. Factors such as
sunlight and drugs could trigger the disorder, but no one cause has been identifi ed and systemic
lupus erythematosus has a complex genetic basis. After receiving veltuzumab treatment, the patient
responded well, with decreased B cells and significantly improved clinical symptoms. Whether the
application can be expanded is debatable ( 42 ). Sometimes, the patients expect to experience the
severe pains that most textbooks describe but that never occurs. Upload Read for free FAQ and
support Language (EN) Sign in Skip carousel Carousel Previous Carousel Next What is Scribd. The
biochemical hallmark of apoptotic cell death is the degradation of DNA into oligosome-sized
fragments by specific endonucleases and the formation of small vesicles from the cell surface, also
known as apoptotic bodies. First, the researchers have concluded that HSCT was effective in the
treatment of SLE and in the alleviation of its symptoms, with its probability of disease-free survival
rate at 55% for five years based on a European analysis and 50% based on this actual study. The pro-
and anti-inflammatory properties of the cytokine interleukin-6. Rituximab: a new monoclonal
antibody therapy for non-Hodgkin’s lymphoma. Therefore, what is important is to find out if certain
specific methods work best with patients who are severely suffering from the disease or those who
do not respond to current strategies and medication. Furthermore, a decrease of T reg only at the site
of inflammation in skin lesions of patients with CLE has recently been observed. Because of the
known effectiveness of HSCT in treating these diseases, Burt et al. (2006) decided to try the same
thing on those with SLE. These autologous CD34-enriched hematopoietic stem cells are infused into
the patient’s body as supportive blood product for the purpose of shortening the interval of
conditioning regimen-related neutropenia. Politicians and medical practitioners are having debates on
possible solutions to this condition. Words: 2053 Length: 7 Pages Document Type: Essay Paper:
46197453 Freud Civilization and Its Discontents Sigmund Freud's volume, Civilization and its
Discontents, he tackles no less than the broad and ambitious concept of man's place in the world.
Aberrant regulation of inducible nitric oxide synthase (iNOS) expression has been noted in UV-
induced lesions of patients with CLE. No cure is available for SLE but treatments for the disease.
However, due to their small molecular weights and lack of receptor-binding Fc structure, the
antibodies cannot mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-
dependent cytotoxicity (CDC) ( 118, 119 ). Profile of atacicept and its potential in the treatment of
systemic lupus erythematosus. Brief report: a randomized, double-blind, parallel-group, placebo-
controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus erythematosus
and active lupus arthritis. The incidence of CLE has only been estimated to be two to threefold
higher than the incidence of SLE. Furthermore, the CXC chemokine receptor R3 ligands CXCL9,
CXCL10, and CXCL11 have been identified as the most abundantly expressed genes in the skin of
patients with CLE. Skin lupus erythematosus lesion area and severity index ——cutaneous lupus
erythematosus disease area and severity index (CLASI) and joint count were significantly improved.